Clinical Trial Update: Immunogenicity of the Hepatitis B Vaccine [Phase 4]

View source ↗

Summary

Phase 4 trial update on the immunogenicity of a Hepatitis B vaccine evaluating vaccine response in impaired populations, including aging-related considerations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: Universidade Federal de Goias | Conditions: Vaccine Response Impaired, Hepatitis B | Phase 4 | Status: UNKNOWN